Searched for *.

1. Evaluation of a novel micro-sampling device, MitaTM, in comparison to dried blood spots, for analysis of praziquantel in <em>Schistosoma haematobium... (Publications)

   Evaluation of a novel micro-sampling device, MitaTM, in comparison to dried blood spots, for analysis of praziquantel in <em>Schistosoma haematobium </em>-infected children in rural Côte d'lvoire

   Relevance:

2. Alpha-1 antitrypsin deficiency: from the lung to the heart? (Publications)

   Alpha-1 antitrypsin deficiency: from the lung to the heart?

   Relevance:

3. Interrupting seasonal transmission of <em>Schistosoma haematobium</em> and control of soil-transmitted helminthiasis in northern and central Côte... (Publications)

   Interrupting seasonal transmission of <em>Schistosoma haematobium</em> and control of soil-transmitted helminthiasis in northern and central Côte d’Ivoire: a SCORE study protocol

   Relevance:

4. Luft (Publications)

   Luft

   Relevance:

5. Public Health Genomics (Publications)

   Public Health Genomics

   Relevance:

6. Lärm (Publications)

   Lärm

   Relevance:

7. Nicht-ionisierende Strahlung (Publications)

   Nicht-ionisierende Strahlung

   Relevance:

8. Local- and regional-scale air pollution modelling (PM10) and exposure assessment for pregnancy trimesters, infancy, and childhood to age 15 years:... (Publications)

   Local- and regional-scale air pollution modelling (PM10) and exposure assessment for pregnancy trimesters, infancy, and childhood to age 15 years: Avon Longitudinal Study of Parents And Children (ALSPAC)

   Relevance:

9. A new soluble and bioactive polymorph of praziquantel (Publications)

   A new soluble and bioactive polymorph of praziquantel

   Relevance:

10. Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss travel clinics (Publications)

    Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss travel clinics

    Relevance:

    Background: Patients increasingly benefit from immunosuppressive/immunomodulatory medications for a range of conditions allowing them a lifestyle similar to healthy individuals, including travel. Howe